Gene Query: WDCP

Dataset Description Geneva Score
Transcriptome analysis of immature and matured human oocytes from patients of young and advanced maternal age 28.66
4sU-seq of HFF exposed to salt and heat stress 20.45
PolyA-sequencing in IMR-32 cells treated with THZ531 or DMSO 15.18
TOP2B disturbed the quality of human oocytes with advanced maternal age 13.09
Regulation of mRNA half-life by an inhibitor of human decapping enzyme Dcp2 following transcription shutoff in HEK293T cells 11.79
m6A-seq data analysis of control and PCIF1 knockdown transcriptome 10.85
ILF2 Regulates RNA Splicing of DNA Damage Response Genes to Confer Poor Prognosis in 1q21-Amplified Multiple Myeloma 10.51
Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function 10.21
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 10.15
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 10.15
Interaction with WDR5 recruits MYC to a small cohort of genes required for tumor onset and maintenance 9.29
Conserved roles for murine mDUX and human DUX4 in activating cleavage stage genes and MERVL/HERVL retrotransposons [RNA-Seq] 7.98
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs (expression) 7.33
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs 7.33
TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation 7.28
Interactions of aCPs with Cytosine-rich Polypyrimidine Tracts Enhance Splicing of Cassette Exons 7.09
BCL6 confers KRAS-mutant NSCLCs resistance to BET inhibitors 6.71
Tracing transcriptome profiles of human oocyte cultured by growth hormone or not in vitro by single cell RNA-seq 6.58
Seletive inhibition of CDK9 in DLBCL cell lines 6.02
Tracking of dCas9-methyltransferase footprints 5.92
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing [RNA-Seq] 5.86
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing 5.86
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 5.58
An integrative analysis of non-coding regulatory DNA variations associated with autism 5.5
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 5.45
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway 5.43
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway [RNA-Seq] 5.43
Genomic expression analysis of K562 cells expressing shRNA targeting lncRNA-IIRX and control cells 5.39
RNA-Sequencing of HepG2 cells treated with TGFBeta 5.25
Transcriptional Modulation of Human Endogenous Retroviruses in Primary CD4+ T Cells Following Vorinostat Treatment 5.12
IDH3a KO RNA-seq 5.09
RNA-Seq in two Ewing sarcoma cell lines: A673 and SKNMC 5.05
Transcriptional study of ARN8 cells treated with novel DHODH inhibitors 4.87
Oncogenic MYC induces a dependency on the spliceosome in human cancer 4.66
Transcriptome analysis in Neobractatin treated cells 4.58
Pitfalls in Single Clone CRISPR-Cas9 Mutagenesis to Fine-map Regulatory Intervals 4.56
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 4.52
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 4.52
A bioinformatics approach reveals novel mechanisms of the OVOL transcription factors in the regulation of epithelial-mesenchymal cell programming and cancer progression. 4.49
RNAseq Analysis in glioblastoma cells treated with Mepazine 4.49
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 4.48
Epigenetic Therapy Increases Therapeutic Efficacy in Myeloproliferative Neoplasms Through Inhibition of Aberrant Inflammatory Signaling 4.46
Valproic acid attenuates hyperglycemia induced complement and coagulation cascade gene expression 4.38
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines 4.32
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines [RNA-Seq] 4.32
Transcriptome analysis of total RNA in human osteosarcoma cell line U2OS before and after inhibition of zinc finger protein ZNF768 4.27
miR-450a acts as a tumor suppressor in ovarian cancer by readjusting energy metabolism 4.26
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 4.24
The LRF/ZBTB7A transcription factor is a BCL11A-independent repressor of fetal hemoglobin 4.05
The bromodomain protein BRD4 regulates splicing during heat shock 3.98
Major hnRNP proteins act as general TDP-43 functional modifiers both in Drosophila and human neuronal cells. 3.86
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 3.84
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1, H1 derived APLNR+ cells, CD31+CD34+ cells and CD43+ cells during human early hematopoietic differentiation 3.73
The cohesin complex prevents Myc-induced replication stress 3.72
Canonical poly(A) polymerase activity promotes the decay of a wide variety of mammalian nuclear RNAs 3.68
Mesenchymal stem/stromal cell engulfment reveals metastatic advantage in breast cancer 3.68
Histone Demethylase-Assisted Somatic Cell Nuclear Transfer Facilitates Derivation of Human Pluripotent Stem Cells 3.66
Tracking distinct RNA populations using efficient and reversible covalent chemistry 3.65
U1 snRNP telescripting regulates size-function stratified human genome 3.64
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [K562] 3.62
Effect of FGF13 depletion on the H460 cell line 3.57
Effect of drugs on transcriptomic profiles 3.53
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 3.53
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis 3.51
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis [RNA-seq] 3.51
A Unique Epigenomic Landscape Defines Human Erythropoiesis (RNA-seq) 3.48
A Unique Epigenomic Landscape Defines Human Erythropoiesis 3.48
SMN deficiency in spinal muscular atrophy causes widespread intron retention and DNA damage 3.43
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes 3.43
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes [RNA-Seq] 3.43
Human germ cell formation in xenotransplants of induced pluripotent stem cells carrying X chromosome aneuploidies 3.38
High-efficiency RNA-based reprogramming of human primary fibroblasts 3.37
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma 3.36
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma [RNA-seq] 3.36
Effect of ER stress on MUC1 kidney disease patient derived cells and and treatment by BRD4780 3.35
RNA-seq analysis of control and Myc-induced U2OS cells 3.34
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 3.3
LncRNA-GAS5 negative regulation of YAP-target genes expression 3.3
RNA-seq analysis of control and ZC3H18-depleted ovarian cancer cells 3.29
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 3.23
RNA-seq analysis of control and CDK12-depleted ovarian cancer cells 3.22
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 3.19
Gene expression and 4sUDRB-seq for NF90/NF110 of human scramble and KD HeLa cells. 3.16
Systematic discovery of endogenous human ribonucleoprotein complexes 3.15
Identification of Nrf2 regulated genes by RNA sequencing 3.1
Nrf2 regulated genes in A549 cells 3.1
LNCaP treated with iBET 3.08
Genome-wide maps of m6A circRNAs identify widespread and cell-type-specific methylation patterns that are distinct from mRNAs 3.02
The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression 3.02
Downregulation of DDX5/DDX17 and REST 3.02
A global identification of PUM1 and PUM2 mRNA targets and their protein cofactors in human seminoma TCam-2 cells 2.99
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 2.92
RNA-seq analysis of RALD iPSCs after in vitro differentiation 2.91
The landscape of alternative splicing in aggressive prostate cancers 2.91
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia (RNA-seq) 2.9
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia 2.9
Single-Cell RNA Sequencing Reveals Metallothionein Heterogeneity during hESC Differentiation to Definitive Endoderm [RNA-Seq] 2.89
‘Naïve’ ESRRB+ iPSCs with the capacity for rapid neural differentiation 2.86
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 2.82
Comparative transcriptomic analysis of human and Drosophila extracellular vesicles reveals extensive conservation 2.82
24hr CA treatment vs. DMSO in HCT116 cells (from 'Identification of CDK8 and CDK19 substrates in human cells using cortistatin A and quantitative phosphoproteomics') 2.81
TNF response in promyelocytic and granulocytic forms of HL60/S4 cells 2.79
Genome-wide chromatin analysis of Ewing sarcoma (RNA-seq) 2.75
Genome-wide chromatin analysis of Ewing sarcoma 2.75
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 2.74
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 (RNA-seq data sets) 2.74
RNA sequence of mRNA in HUVEC cells after depleting EGFL6 2.72
Sodium butyrate ameliorates aSyn-induced transcription deregulation and DNA damage 2.65
N6-methyladenine DNA Modification in Glioblastoma 2.6
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 2.6
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation [bulk] 2.6
Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation 2.59
Genome-wide discovery of human splicing branchpoints [RNAse] 2.58
RG/RGG boxes are common binding motifs in RNA-G-quadruplex-interacting proteins 2.55
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 2.55
The E3 ubiquitin ligase HectD1 suppresses EMT and metastasis by targeting the +TIP protein ACF7 for degradation 2.54
Genome-wide transcriptome analysis of NIPBL iPSC and commited cardiomyoctes 2.53
microRNA suppresses prostate cancer stem cells and metastasis by inhibiting a cohort of pro-metastasis targets including CD44, Rho GTPases and EZH2 2.51
Transcription-dependent control of stem cell self-renewal and differentiation by the splicing factor U2AF1 2.49
ETV7 and interferon response 2.48
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha 2.48
Gene expression changes after LOC550643 silencing 2.46
Reversible LSD1 Inhibition with HCI-2509 induces the p53 gene expression signature in high-risk neuroblastoma cells 2.46
RNA sequencing of HepG2 cells treated with estradiol or estrogen receptor agonist 2.45
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia [RNA-seq] 2.43
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia 2.43
A transcriptome-wide divergence in protein translation scales with LIN28B expression 2.41
Genome wide miR-191 target profile determined by RIP and gene expression profiling 2.41
miR-191 regulates human cell proliferation and directly targets multiple oncogenes [seq] 2.41
Genetic Tagging During Human Mesoderm Differentiation Reveals Tripotent Lateral Plate Mesodermal Progenitors 2.41
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells 2.41
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells [RNA-seq] 2.41
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells 2.4
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells [RNA-seq] 2.4
MYC dependent mRNA translation shapes gene expression and cell biology 2.38
FUS KO mRNA sequencing and anti-FUS RNA immunoprecipitation sequencing 2.36
RNA-seq and m6A-seq of AML cells with FTO knockdown or inhibition 2.35
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 2.34
Epigenetic silencing of the tumor suppressor RASSF4 favors multiple myeloma progression 2.32
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 2.31
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice [HCT116_RNA-seq] 2.3
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice 2.3
RNA-Seq of cKIT+ sorted cells from 16-16.5 week old fetal testes and ovaries and RNA-Seq of TRA-1-60+ H1 hESCs 2.29
ELF4 is a target of miR-124 and promotes neuroblastoma proliferation and undifferentiated state 2.28
RNA expression profiling of human mPB or CB-derived CD34+ cells treated with UM171 at different doses 2.27
Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection 2.27
RNA-sequencing of isogenic primary, pre-malignant immortalized, and Ras-transformed human mammary epithelial cells 2.26
SNHG5 siRNA knock down in HCT116 cells 2.25
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 2.23
RNAseq of PRMT4KD in human cord blood derived CD34+ cells 2.21
Circular RNAs in the mammalian brain are highly abundant, conserved, and dynamically expressed 2.19
Induction of Prolonged Early G1 Arrest by CDK4/CDK6 Inhibition Reprograms Lymphoma Cells for Durable PI3Kδ Inhibition Through PIK3IP1 2.19
circ-ZNF609 regulates G1-S progression in Rhabdomyosarcoma 2.18
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage 2.16
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage (RNA-seq) 2.16
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor [RNA-seq] 2.16
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor 2.16
Transcriptional effect of ETV1 knockdown in melanoma cells 2.15
Cerebellar differentiation in Ataxia-Telangiectasia 2.14
Cajal bodies are linked to genome conformation 2.14
Cajal bodies are linked to genome conformation [RNA-Seq] 2.14
2.13
Next Generation Sequencing Facilitates Quantitative Analysis of HIV-1 Latency in Central Memory T Cells 2.13
The ribosomal prolyl-hydroxylase OGFOD1 decreases during cardiac differentiation, modulates translation and spliceosomal processes 2.12
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes 2.11
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells 2.11
Transcriptional profiling of JEG3 cells with HLA-G ablation via deletion of Enhancer L 2.11
The BCL6 RD2 domain governs commitment of activated B-cells to form germinal centers 2.1
RNA sequencing for human induced pluripotent stem cell cardiomyocyte differentiation 2.1
Cooperation between TLX1 and the NUP214-ABL1/STAT5 signaling in T-cell acute lymphoblastic leukemia 2.1
Splicing towards noncoding isoforms in colorectal carcinoma is associated with tumor hypoxia and the DNA damage response 2.09
Identification of altered developmental pathways in human juvenile HD iPSC with 71Q and 109Q using transcriptome profiling 2.09
Diffuse Large B Cell Lymphoma cell line with Acquired Resistance to PI3Kδ Inhibitor Idelalisib 2.08
PolyA-sequencing in Kelly and Kelly E9R neuroblastoma cells treated with THZ531 or DMSO 2.08
Knockdown of ADNP in HCT116 colon cancer cells 2.08
Novel Targeting of Transcription and Metabolism in Glioblastoma 2.08
Transcriptome analysis of human embryonic stem cells (hESCs) and human fibroblasts upon rapamycin 2.08
Dissection of estrogen receptor alpha signaling pathways in osteoblasts using RNA-sequencing 2.07
Effect of from Human Umbilical Vein Endothelial Cells 2.06
Spliceosomal disruption of the non-canonical BAF complex in cancer 2.06
Global gene expression profile of dasatinib-resistant RCH-ACV cells 2.05
HITS-CLIP analysis uncovers a link between the Kaposi's sarcoma associated herpesvirus ORF57 protein and host pre-mRNA metabolism 2.04
Transcriptome analysis of SKI knock-out in HL60 cells 2.04
Combined cistrome and transcriptome analysis of SKI in AML cells identifies SKI as a co-repressor for RUNX1 2.04
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors 2.01
Identification of transcripts altered upon LIN-41 knockdown in human embryonic stem cells 2.01
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 2.0
Presence of NAD+-capped RNA in human cells: function and removal by the DXO deNADing Protein 2.0
Time series total RNA sequencing of a differentiation of human embryonic stem cells towards trophoblast lineage 1.99
12hr 5-FU treatment vs. DMSO in SJSA cells (from 'A kinase independent role for CDK19 in p53 response') 1.97
Transcriptomic profiling discloses molecular and cellular events related to neuronal differentiation in SH-SY5Y cells 1.95
Differential gene expression tools exhibit substandard performance for long non-coding RNA-sequencing data 1.94
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency 1.93
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency (RNA-Seq) 1.93
Impact of GDF15 expression of ovarian cancer cell on stroma and Cisplatin responses 1.92
Transcription differences in DLBCL cell lines U2932, DOHH2 on treatment with TK compound compared to DMSO 1.91
A SIRT1-centered Circuitry Regulates Breast Cancer Stemness and Metastasis 1.91
LMO1 Synergizes with MYCN to Promotes Neuroblastoma Initiation and Metastasis 1.89
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 1.89
Functional role of SLIT2 and ROBO1 in trophoblasts 1.89
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma 1.88
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma [RNA-seq] 1.88
Fisetin induces autophagy in pancreatic cancer cells via endoplasmic reticulum stress- and mitochondrial stress-dependent pathways 1.88
Gene expression analysis of BRD4 knockdown in HT-29 and HCT116 cells 1.88
Gene expression profile of human multiple myeloma cell line MM.1S after knockdown of KDM6B 1.88
Patient iPSC-derived neural stem cells display progressive enlargement of lysosomes and disruptions of glycosaminoglycan pathway and autophagy in concordance with clinical severity of Mucopolysaccharidosis I 1.88
Quantitative comparison between cellular mRNAs and exosomal mRNAs in human iPSC-derived motor neurons 1.87
Codon usage optimization in pluripotent embryonic stem cells [RNA-seq] 1.87
Gata6 potently initiates reprogramming of pluripotent and differentiated cells to extraembryonic endoderm stem cells [ChIP-Seq & RNA-Seq] 1.87
Gata6 potently initiates reprogramming of pluripotent and differentiated cells to extraembryonic endoderm stem cells 1.87
Quantitative analysis of bi-modal binding of BET proteins at promoters predicts I-BET sensitivity 1.87
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq 2] 1.86
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation I 1.85
Circular RNAs are down-regulated in KRAS mutant colon cancer cells and can be transferred to exosomes 1.84
Identification of global regulators of T-helper cell lineage specification 1.84
Identification of global regulators of T-helper cell lineage specification (RNA-Seq) 1.84
Glutaminolysis is a metabolic dependency in FLT3 ITD Acute Myeloid Leukemia unmasked by FLT3 Tyrosine Kinase Inhibition 1.84
HMGA2 Promotes Long-Term Engraftment and Myelo-Erythroid Differentiation of Human Hematopoietic Stem and Progenitor Cells 1.84
Non-transmissible measles virus vector with segmented RNA genome establishes different types of iPSCs from hematopoietic cells 1.83
Ambient O2 pressure induces NF-kB1/RelA related inflammatory response in human lung epithelial cells in vitro 1.82
HEK293 TFAM Knockout Expression Study 1.81
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function 1.8
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function [Rnase-Seq] 1.8
Transcriptional profile of CAOV2 ovarian cancer cells with TAZ silencing 1.8
RNA-seq Profiles in RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 1.8
RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 1.8
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 1.79
Dissecting the dynamics of signaling events in the BMP,WNT and NODAL cascade during self-organized fate patterning in human gastruloids 1.79
RNA-seq of UGP2 mutant human embryonic stem cells and in vitro differentiated neural stem cells 1.79
An intramolecular salt bridge linking TDP43’s RNA recognition motifs dictates RNA binding, protein stability and TDP43-dependent neurodegeneration 1.78
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 1.77
Silencing p300 in MCF7 cells to study expression and alternative splicing 1.77
MYCL and EP400 are required for Max and MCPyV mediated gene activation 1.76
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines [HTS] 1.75
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines 1.75
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 1.74
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 1.74
RNA-seq analysis of activated plasmacytoid dendritic cell subsets after viral infection 1.74
Uridylation by TUT4 and TUT7 marks mRNA for degradation 1.74
m6A-RNA mapping, SND1-RNA binding profile mapping and SND1-depletion in KSHV-infected B-lymphocytes 1.73
Gene expression in PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition. 1.72
PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition 1.72
The splicing factor RBM25 controls MYC activity in Acute Myeloid Leukemia 1.71
UV_24h_GRO-Seq 1.7
CLIC5: a novel ETV6 target gene in childhood acute lymphoblastic leukemia 1.69
3’ Uridylation Expands miRNA Target Repertoire 1.68
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 1.66
PAX3-FOXO1 requires BRD4 to drive oncogene addiction in RMS cells [RNA-seq] 1.66
Epigenetic Lanscape and BRD4 Transcriptional Dependency of PAX3-FOXO1 Driven Rhabdomyosarcoma 1.66
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 1.66
Enriched retinal ganglion cells derived from human embryonic stem cells (RNA-seq) 1.66
Nucleotide excision repair capacity increases during differentiation of human embryonic carcinoma cells into neurons and muscle cells 1.62
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation 1.62
Splicing and gene expression changes in human MDAM-MB231 breast cancer cells with TRA2B knockdown 1.62
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures 1.61
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures [RNA-Seq] 1.61
Spatially Constrained Tandem Bromodomain Inhibition Bolsters Sustained Repression of BRD4 Transcriptional Activity for TNBC Cell Growth 1.6
Analysis of regulatory element evolution between human and mouse reveals a lack of cis-trans compensation 1.6
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_RNA-seq] 1.59
SETDB2 links E2A-PBX1 to cell cycle dysregulation in acute leukemia through CDKN2C repression [sequencing] 1.59
Transcriptome profiling of self-renewing hESCs and multipotent mesoderm progenitor cells as a function of substrate stiffness 1.57
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells 1.57
Prolyl hydroxylation regulates protein degradation, synthesis, and splicing in human induced pluripotent stem cell-derived cardiomyocytes 1.56
Transcriptome analysis upon C6orf203 silencing 1.56
RNASeq of MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 1.56
Functional interdependency of BRD4 and DOT1L in MLL leukaemia 1.56
UV-Irradiation Induces a Noncoding RNA that Functionally Opposes the Protein Encoded by the Same Gene 1.55
Transcriptome analysis of SH-SY5Y cells after knockdown of circSLC45A4 1.54
RNA-seq of cancer cell lines treated with T-025 1.54
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference [RNA-Seq] 1.54
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference 1.54
Inhibition of the integrin alpha-V beta-3 reverts the paradoxical effect of levothyroxine replacement during bexarotene therapy in cutaneous T-cell lymphoma 1.54
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation 1.53
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 1.52
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 1.52
RNA-Sequencing experiment for effects of PKF115-584 treatment on four T-ALL cell lines (RPMI8402, HPB-ALL, Jurkat, CCRF-CEM). 1.52
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 1.52
ARID1A regulates condensin II distribution and chromosomal partition 1.5
ARID1A regulates condensin II distribution and chromosomal partition [RNA-seq] 1.5
MLL-AF4 binds directly to a BCL-2 specific enhancer and impacts H3K27 acetylation 1.5
Host transcriptome analysis of Aspergillus fumigatus infection in Airway Epithelial Cells 1.5
A faithful in vivo model of human MLL-AF4 proB acute lymphoblastic leukemia 1.49
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq SS] 1.49
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 1.48
Genomic basis for clinical response to histone deacetylase inhibition in advanced urothelial carcinoma 1.48
Transcriptomic profiling of human HAP1 cells before and after nutrient deprivation 1.47
Human HAP1 cells before and after nutrient deprivation 1.47
Generation of Brain Region-specific Organoids using a Miniaturized Spinning Bioreactor and Modelling ZIKV Exposure 1.47
O-glcnAc reprograms cellular energetics 1.46
Gene expression in GBM with Cav3.2 inhibition 1.45
Loss of CREBBP results in gene expression repression in lymphoma cells 1.45
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells 1.45
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line [RNA-Seq] 1.44
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line 1.44
Total RNA profiles associated with DDX3 wild-type (WT) or R534H variant expression with or without sodium arsenite treatment [RNA-seq] 1.42
Profiles of ribosome-associated mRNAs regulated by expression of wild-type (WT) or R534H variant of DDX3 with or without Sodium Arsenite treatment 1.42
Functional role of CPPED1 in trophoblasts. 1.42
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 1.41
Global Transcriptional analysis of human spinal cord and neocortical neuroepithelial stem (NES) cells 1.41
KSHV vIRF3 promotes angiogenesis of lymphatic endothelial cells (LECs) 1.38
RNA-sequencing of the GSI treatment of the CUTLL1 cell line 1.37
Transcriptome Analysis of CircMRPS35 mediated mRNA expression profiles 1.36
Effect of low-dose sorafenib and alkylating agents in inflammation and angiogenesis in breast cancer 1.36
PRDM1 inhibits proliferation of human colon cancer organoids 1.36
AhR activity directs BRAF inhibitors resistance in metastastic melanoma 1.36
Transcriptome-wide analysis of IL2RA enhancer activation by CRISPRa 1.35
RNA-seq of naive and primed ES cells 1.35
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 1.34
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 1.34
RNA-seq analysis of the role of HBO1 (KAT7/MYST2) in the ovarian cancer cell line UWB1.289. 1.34
Chemotherapeutic drugs inhibiting Topoisomerase 1 activity inhibit TNF-induced inflammatory gene expression 1.33
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 1.33
Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice (human RNA-Seq) 1.33
Transcriptomic analysis to functionally map the intrinsically disordered domain of EWS/FLI [Experiment 1] 1.31
Global transcriptome analysis of HAP1 cells 1.31
Molecular Criteria for Defining the Naive Human Pluripotent State 1.3
Transcriptome analysis of genetically matched human induced pluripotent stem cells disomic or trisomic for chromosome 21 1.29
Meta-organization of Translation Centers Revealed by Proximity Mapping of Endoplasmic Reticulum Ribosome Interactors 1.28
A20 regulates canonical wnt-signaling through an interaction with RIPK4 1.27
Genome-wide discovery of human splicing branchpoints 1.25
Gene expression profiling in lung and breast cancer cells treated by Bloom-specific siRNAs 1.24
pSILAC mass spectrometry reveals ZFP91 as novel IMiD dependent substrate of the CRL4CRBN ligase 1.24
Expression analysis of PC3 cells treated with scramble AON or AON directed against MBNL1 1.22
Differentially Expressed Genes upon Knockdown of ZRANB1 or EZH2 in LM2 Cells 1.22
Studying iPSCs from a hibernating mammal reveals molecular mechanisms of cold resistance in neural tissues 1.21
Transcriptome analysis of V336Y mutant mitochondrial ribosomal protein in human HEK293 cell line 1.2
Human cells contain natural double-stranded RNAs with potential regulatory capacity 1.19
RNA-seq of resting and activated CD4+ T cells +-JQ1 1.18
Transcriptional dependencies in diffuse intrinsic pontine glioma 1.18
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition 1.16
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition [RNA-seq] 1.16
Probing the Global Cellular Responses to Lipotoxicity Caused by Saturated Fatty Acids 1.16
RNA sequencing analysis of human embryonic stem cells and axial progenitors 1.15
Determining mRNA half-lives on a transcriptome-wide scale 1.15
Functional significance of the HIV-1 Tat signature amino acid residues 1.15
Novel Non-catalytic Substrate-selective p38α-specific MAPK Inhibitors with Endothelial-Stabilizing and Anti-inflammatory Activity 1.13
Single-cell transcriptomics of human oocytes: environment-driven metabolic competition and compensatory mechanisms during oocyte maturation 1.13
Total RNA-seq in ALL-SIL upon TLX1 knockdown 1.13
Human Embryoid Body Transcriptomes Reveal Maturation Differences Influenced by Size and Formation in Custom Microarrays 1.12
To identify transcripts that are differentially expressed in the MYCN amplified vs MYCN non-amplified cell lines using Next Generation Sequencing 1.12
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma [RNA-Seq] 1.11
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma 1.11
Cell Type-Specific Chromatin Signatures Underline Regulatory DNA Elements in Human Induced Pluripotent Stem Cells and Somatic Cells 1.1
Histone deacetylase inhibition enhances antimicrobial peptide but not inflammatory cytokine expression upon bacterial challenge 1.08
CNOT1 and Transcriptomic Landscape of a HeLa Cell Line 1.07
Transcriptomic analysis of ERR alpha orphan nuclear receptor 1.07
A Primate lncRNA Mediates Notch Signaling During Neuronal Development by Sequestering miRNA [SHSY5Y cells] 1.06
Circular RNA profiling reveals the different distribution/characteristic and possible transport mechanism among the subcellular fractions 1.05
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 1.05
Gene expression profile in breast cancer cells 1.05
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 1.04
Iron response of HepG2 cells 1.04
KDM1A confers invasive and metastatic attributes in lung adenocarcinoma by modulating a non-canonical Integrin ß3-KRAS signaling pathway 1.04
U2AF1 mutations alter splice site recognition in hematological malignancies 1.03
Modulation of nonsense-mediated decay by rapamycin 1.02
Inheritable Silencing of Endogenous Genes by Hit-and-Run Targeted Epigenetic Editing 1.02
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 1.02
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection [RNA-seq] 1.01
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection 1.01
Splicing function of mitotic regulators links R-loop mediated DNA damage to tumor cell killing 1.01
Differential YAP expression in glioma cells induces cell competition and promotes tumorigenesis 0.99
PT2385 HIF2A inhibitor treatment of patient derived orthotopic xenograft neuroblastoma cells in the presence or absence of hypoxia 0.99
SMUG1 promotes telomere maintenance through telomerase RNA end-processing 0.94
Glioma Stem Cell Specific Super Enhancer Drives Polyunsaturated Fatty Acid Synthesis to Support EGFR Signaling 0.94
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 0.92
m6A level and isoform characterization sequencing (m6A-LAIC-seq) reveal the census and complexity of the m6A epitranscriptome 0.91
Transcriptional profile of human STAT1-/- fibroblasts expressing LY6E or empty control vector 0.91
Analysis of the senescent transcriptome upon expression of a ZFP36L1 phosphomutant 0.87
Global transcript structure resolution of high gene density genomes through multi-platform data integration: Illumina RNA-Seq 0.86
Total RNA sequencing of prospective axial stem cell cultures derived from human pluripotant stem cells 0.85
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape 0.85
microRNAs with an AAGUGC seed motif constitute an integral part of a signaling network driving NSCLC cell proliferation 0.83
Transcriptomic analysis of iPSC and ESC challenged with atmospheric or physiological oxygen 0.82
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 0.82
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 0.81
Transcriptomics analysis of gene expression in normal and METTL3 or WTAP deficient Human HeLa cells 0.8
Genome-wide Gene Expression Profiling in DLBCL Cell Lines Treated with CUDC-907 0.79
Transcriptome analysis of human embryonic stem cells (hESCs) upon siRNA-mediated knockdown of hESC-essential genes 0.79
Adaptation of the Kinome Promotes Resistance to BET Bromodomain Inhibitors in Ovarian Cancer 0.78
MYC interacts with the G9a histone methyltransferase to drive transcriptional repression and tumorigenesis 0.78
Differential Protein Occupancy Profiling of the mRNA Transcriptome 0.78
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_compound] 0.77
Gene expression profiles of ibrutinib-responsive and ibrutinib non-responsive cells in ERBB4 expressing cancer cell lines 0.75
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (scRNA-Seq) 0.74
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 0.74
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [whole transcriptome RNA-seq] 0.73
The CDK7 Inhibitor THZ1 Alters RNA Polymerase Dynamics at the 5’ and 3’ Ends of Genes 0.73
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 0.71
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies [RNA-seq data set 2] 0.7
Molecular characterization of BRSK2 and BRSK1 kinases as negative regulators of the NRF2 transcription factor 0.69
WNT signaling memory is required for ACTIVIN to function as a morphogen 0.69
EWS-Fli and LNC regulated genes in comparison to GFP samples 0.68
Transcriptome profiling of 5 human adenocarcinoma cell lines 0.67
Sequence dependency and regulatory function of dimeric NOTCH1/RBPJ complexes on coding and non-coding transcription in T-lymphoblastic leukemia 0.67
RNA-sequencing of mRNAs from control and CAP-D3 deficient Salmonella infected HT-29 cells 0.67
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [RNA-Seq] 0.66
Gene expression analysis upon mtDNA depletion 0.64
Gene expression analysis upon mtDNA depletion [RNA-seq] 0.64
Transcriptome profiling of H1-iCas9 cells grown on laminin and on MEFs 0.64
mRNA sequencing of clinical-grade neural stem cells derived from human ES cells 0.64
PolyA-sequencing in IMR-32 neuroblastoma cells with shRNA mediated depletion of CDK12, CDK13 or GFP. 0.63
Real-time observation of light-controlled transcription in living cells 0.62
Human naïve pluripotent stem cells exhibit X chromosome dampening and X-inactivation (RNA-Seq) 0.61
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 0.61
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 0.59
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 0.59
Small-molecule-based Human Genome G4 Profiling Reveals Potential Gene Regulation Activity 0.59
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 0.58
Effect of digoxin treatment on the gene and alternative splice expression in human pluripotent stem cells- derived mesenchymal stem cells 0.58
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration [RNA-seq2] 0.58
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 0.57
Controlling for gene expression changes in transcription factor protein networks. 0.57
Global transcriptome analysis of WT versus HEB-/- hESCs 0.57
Landscape and variation of RNA secondary structure across the human transcriptome 0.56
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 0.55
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 0.54
mRNA expression data from ESCs derived by polar body transfer reconstructed embryos (PBTESCs) 0.54
Activation of the p53 transcriptional program sensitizes cancer cells to Cdk7 inhibitors 0.54
RNA-seq expression data from EB-HSPC after AM580 treatment compated to DMSO-trated and FL-HSPCs 0.54
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 0.52
Transcriptome Analysis Reveals Distinct Responses to Physiologic versus Toxic Manganese Exposure in Human Neuroblastoma Cells 0.51
RNA-seq of synchronized S phase or G2 phase cells treated with an ATR inhibitor 0.51
RNA-Seq of cKIT+ sorted cells from 53-137 day old fetal testes and ovaries and RNA-Seq of TRA-1-81+ H1 and UCLA1 hESCs. 0.5
cKIT+ sorted cells from 57-137 day old fetal testes and ovaries 0.5
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells (RNA-seq) 0.5
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells 0.5
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 0.48
RNA sequencing with KSHV infection and enrichment for circular RNAs 0.48
Global transcriptome analysis in the MYCN-amplified neuroblastoma cell line IMR5-75 upon inducible MYCN-knockdown 0.47
Role of FGFR1 in neuronal devlopment 0.47
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 0.45
Zika virus infection reprograms global transcription of host cells to allow sustained infection 0.45
The Genetic Landscape of Diamond-Blackfan Anemia 0.45
Protein kinase A-mediated phosphorylation regulates STAT3 activation and oncogenic EZH2 activity 0.45
Transcriptome sequencing of K-562 cells 0.44
Investigsting the role of NF-ĸB p50 S80 phosphorylation in regulating TNFα-induced transcription in HEK293T cells 0.44
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 0.44
Genomic profiling of human spermatogonial stem cells [BulkRNA-Seq] 0.44
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) 0.43
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 0.42
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies 0.41
RUVBL1/RUVBL2 ATPase Activity Drives PAQosome Maturation, DNA Replication and Radioresistance in Lung Cancer 0.4
m6A-dependent regulation of messenger RNA stability 0.4
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 0.4
Identification of Resistance Genes to BRAF Inhibitor in Melanoma by piggyBac Transposon Activation Mutagenesis Screen 0.39
H19 regulates hepatic glucose production by epigenetic modification of Hnf4* 0.38
Identification of genes regulated by Long noncoding RNA H19 in hepatic cells 0.38
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 0.38
FMRP-associated MOV10 facilitates and antagonizes miRNA-mediated regulation 0.38
Uridylation by TUT4 and TUT7 marks mRNA for degradation [RNA-Seq] 0.38
Cell cycle dynamics of human pluripotent stem cells primed for differentiation 0.36
Mutational landscape of splicing genes and functional consequences across 33 cancer types 0.32
Generation of low passage high grade serous ovarian cancer cell lines from primary tumors 0.31
Myc activation coordinates gene transcription and protein translation responses 0.31
Total RNA-seq in ALL-SIL upon JQ1 inhibition 0.3
Inhibiting the oncogenic translation program is an effective therapeutic strategy in multiple myeloma 0.29
Activin/Smad2-induced H3K27me3 reduction is crucial to initiate mesendoderm differentiation of ES Cells 0.29
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown 0.28
single cell RNA-seq from GM12878 (ENCSR673UIY) 0.27
ELAVL2-regulated transcriptional networks in human neurons link atlernative splicing, autism and human neocortical evolution 0.26
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 0.26
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq1] 0.25
Small-molecule targeting of brachyury transcription factor addiction in chordoma 0.24
Systematic analysis of gene expression profiles controlled by hnRNP Q and hnRNP R, two closely related human heterogeneous nuclear ribonucleoproteins. 0.23
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 0.23
Evaluating and comparing the Transcriptome of (human) Hek 293 based cells, expressing either CHD3 or CHD4 0.22
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 0.21
RNA sequencing of MDA-MB231 and U2OS cancer cell lines exposed to the alkylating agent methyl methanesufonate (MMS) and classical chemotherapeutics  0.21
HSB-2 cells stably expressing LDB1 or mutant LDB1 proteins 0.21
High Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML 0.19
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations 0.19
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations [RNA-seq] 0.19
Genome-wide hsa-miR-503, hsa-miR-103, and hsa-miR-494 target profiles 0.17
hsa-miR-503, hsa-miR-103, and hsa-miR-494 genome wide target profiles [RNA-Seq and RIP-Seq] 0.17
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 0.17
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 0.16
CDK12 mediated transcriptional regulation in U2OS cells 0.16
Tracking transcriptional changes in a species-specific manner during experimental hepatoblastoma progression in vivo 0.16
Genome-wide search for differentially expressed RNAs responsible for the effects induced by Ebola virus replication and transcription 0.15
Function and hormonal regulation of GATA3 in human first trimester placentation 0.13
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 0.12
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.12
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.12
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 0.12
Epigenome Editing by a CRISPR/Cas9-Based Acetyltransferase Activates Genes from Promoters and Enhancers 0.1
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 0.09
FOXF1 defines the core-regulatory circuitry in gastrointestinal stromal tumor (GIST) 0.09
Expression profile of GIST48 cells with siETV1 or siFOXF1 knockdown 0.09
Single cell analysis of HSV-1 infection reveals anti-viral and developmental programs are activated in distinct sub-populations with opposite outcomes 0.09
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 0.06
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HOM] 0.05
Transcriptome analysis of the HepG2 cells expressing hepatic transcription factors 0.05
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.04
p53 activity results in DNA replication fork processivity 0.03
The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression 0.03
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 0.02
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 0.02
FOXP1 orchestration of ASD-relevant signaling pathways. 0.02
Differential LINE-1 retrotransposition in induced pluripotent stem cells between humans and great apes 0.01
Gene expression changes due to PARP knockdown in human cells 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation